Larry A Harshyne Jr

Larry A. Harshyne, PhD

Contact Dr. Harshyne

1020 Locust Street
Jefferson Alumni Hall
Suite 454
Philadelphia, PA 19107

(215) 503-9893

Most Recent Peer-reviewed Publications

  1. Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes
  2. Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes
  3. Human parechovirus and enterovirus initiate distinct CNS innate immune responses: Pathogenic and diagnostic implications
  4. Immune biomarkers of treatment failure for a patient on a phase i clinical trial of pembrolizumab plus radiotherapy
  5. Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients
  6. Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide
  7. Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm
  8. The somatic genomic landscape of glioblastoma
  9. Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers
  10. c-Jun NH2-terminal kinase 2α2 promotes the tumorigenicity of human glioblastoma cells
  11. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells
  12. Novel Training Concepts and Techniques Used to Increase Safety Awareness in the Laboratory Animal Facility
  13. A role for class A scavenger receptor in dendritic cell nibbling from live cells
  14. Changes in dendritic cell migration and activation during SIV infection suggest a role in initial viral spread and eventual immunosuppression
  15. Erratum: Dendritic cells acquire antigens from live cells for cross-presentation to CTL. (The Journal of Immunology (2001) 166 (3717-3723))
  16. Dendritic cells acquire antigens from live cells for cross-presentation to CTL
  17. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: Implications for dendritic cell-based vaccines